Intrinsic Value of S&P & Nasdaq Contact Us

Allurion Technologies Inc. ALUR OTC

Other OTC • Healthcare • Medical - Devices • US • USD

SharesGrow Score
37/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.50
+177.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Allurion Technologies Inc. (ALUR) , forward earnings yield 625.00%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+177.8%).
  • Forward P/E 0.2
  • Analyst consensus target $2.50 (+177.8% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 37/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
37/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
MOAT
35/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — ALUR

Valuation Multiples
P/E (TTM)0.0
Forward P/E0.2
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.45
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-3.81
Forward EPS (Est.)$5.75
Book Value / Share$0.00
Revenue / Share$2.02
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield625.00%
Dividend Yield0.00%
Analyst Target$2.50 (+177.8%)

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2020 $0.00 $0.00 $-5.17K -
2021 $-7.33 $38.24M $-12.39M -32.4%
2022 $-1.40 $64.21M $-37.74M -58.8%
2023 $-57.75 $53.47M $-80.61M -150.8%
2024 $-11.64 $32.11M $-26.15M -81.4%
2025 $-3.81 $15.23M $-28.76M -188.8%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message